Great walk celebrating improvements in melanoma survivorship organized by ⁦John M. Kirkwood⁩ and ⁦AIM at Melanoma Foundation⁩. ⁦⁦UPMC Hillman Cancer Center⁩

✅ 60 miles in the inaugural Rush to Crush Cancer ride. Thanks to everyone who supported #TeamMelanomore and UPMC Hillman Cancer Center

A non-cancer related tweet. A conversation with my wife, Lakshmi Satya (a UPMC Health Plan attorney) to celebrate diversity and #AAPI heritage month. An important dialogue, with insights on the importance of #AAPI in our culture achp.org/aapi-heritage-…

Had a great time discussing dev therapeutics, I/O and skin cancer #ASCO23 abstracts with Jason Luke, MD, FACP recorded by #ASCODailyNews and #ASCO staff. Great progress, high impact data, including some practice changing results. Listen to it here (dailynews.ascopubs.org/do/podcast-asc…)

Best meeting badge tags of #asco23 courtesy of Dr. Roman Groisberg. ASCO Merck

You are extraordinary and courageous, and an example to us all. Your open & honest video, and willingness to push the #glioma field forward using all we Melanoma Institute Australia have learnt from #melanoma in such a personal way is inspiring.

Great discussion about #ASCO2023 abstracts covering #melanoma, #IO and all things #immunotherapy with my good friend and colleague Jason Luke, MD, FACP. Catch it here (dailynews.ascopubs.org/do/podcast-spo…). UPMC Hillman Cancer Center

Improve patient outcomes and earn CME, CNE, CPE, or MOC credits by attending the Society for Immunotherapy of Cancer #virtual Advances in Cancer Immunotherapy ™ (#LearnACI) Skin Cancers program on Sept 6. Register and attend with a colleague! sitcancer.org/education/aci/….

Super excited to support Robert Ferris, MD, PhD in VP election Society for Immunotherapy of Cancer! Bob is a visionary physician-scientist & executive leader whose career is dedicated to translational #immunology & #immunotherapy. Amazing potential to lead the society. Plz vote for Bob! contentsharing.net/actions/email_…

CD8+ T cells were implicated in PD-1 response in 2014 (Tumeh, Nat 2014). We now have automated quantitative assay validated in melanoma (academic.oup.com/oncolo/article…). Congratulations Dylan Fortman for getting this over the finish line. #pittmed UPMC Hillman Cancer Center

Remarkably beautiful weather for the second annual Rush to Crush Cancer ride. #TeamMelaNoMore raised almost $5k and had a great time supporting UPMC Hillman Cancer Center!

Congratulations to Florent Amatore, outstanding AP-HM - Hôpitaux Universitaires de Marseille physician scientist, presenting data from a pilot neoadjuvant study of #pembrolizumab in cSCC. N=26, pCR 59%, improved EFS with responders, very exciting spatial domain data from @PredXBio. UPMC Hillman Cancer Center Pitt Health Sciences

Today BlueCrossBlueShield denied coverage of scans to my patient with #metastaticmelanoma, requiring a peer-to-peer for standard of care imaging. To add insult to injury, they explicitly say that an NP or PA cannot do the peer-to-peer, must be an attending. These highly trained APPs

Congratulations to TriSalus Life Sciences Chandra Ghosh and colleagues for this report detailing preclinical efficacy of PEDD-delivered #TLRa nelitolimod into liver mets(jitc.bmj.com/panels_ajax_ta…). Clinical data from #PERIO-01 previously been presented by Sapna Patel at SITC 2023.

Great work by HCC summer academy student @RomanAllen who evaluated role of non-nutritive sweeteners (NNS) in affecting outcomes to cancer immunotherapy. Akin to preclinical observations, NNS may impede ICI efficacy. More to come. ⁦UPMC Hillman Cancer Center⁩